Welcome to our dedicated page for Ix Acquisition SEC filings (Ticker: IXQWF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Ix Acquisition's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Ix Acquisition's regulatory disclosures and financial reporting.
IX Acquisition Corp. is soliciting shareholder approval at an extraordinary meeting on October 8, 2025 to (1) amend its memorandum and articles to permit a one-year extension (monthly, up to 12 months) of the deadline to complete a business combination to October 12, 2026, (2) ratify CBIZ CPAs P.C. as auditor for 2025, and (3) approve an adjournment option. If approved, public shareholders may elect to redeem shares for a pro rata portion of the trust account before the meeting; the trust held approximately $19.8 million on September 19, 2025, implying about $12.31 per public share. Sponsor contributions of up to the lesser of $40,000 or $0.03 per outstanding public share per month would be made as interest-free loans if the extension is approved. If the extension fails and no business combination occurs, the company will wind up and redeem public shares from the trust.
